<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03302416</url>
  </required_header>
  <id_info>
    <org_study_id>PRO16030242</org_study_id>
    <secondary_id>R21DA042633</secondary_id>
    <nct_id>NCT03302416</nct_id>
  </id_info>
  <brief_title>CRF - Nociceptin Receptor Interactions</brief_title>
  <official_title>In Vivo Imaging of Corticotropin-releasing Factor - Nociceptin Receptor Interactions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine if [C-11]NOP-1A receptor binding (VT) can be altered by an intravenous
      hydrocortisone (cortisol) challenge through CRF-NOP interactions
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Examines changes in [C-11]NOP-1A pharmacokinetics caused by an intravenous hydrocortisone
      challenge (1 mg/kg)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2016</start_date>
  <completion_date type="Actual">June 1, 2019</completion_date>
  <primary_completion_date type="Actual">June 1, 2019</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Baseline [C-11]NOP-1A scan Post-hydrocortisone [C-11]NOP-1A scan</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>[C-11]NOP-1A volume of distribution expressed relative to total plasma concentration</measure>
    <time_frame>Baseline and 3.5 hours post-hydrocortisone</time_frame>
    <description>VT</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>[C-11]NOP-1A PET Scan conditions</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Baseline condition and Post-hydrocortisone (1 mg/Kg, intravenous) condition</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydrocortisone</intervention_name>
    <arm_group_label>[C-11]NOP-1A PET Scan conditions</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>[C-11]NOP-1A</intervention_name>
    <arm_group_label>[C-11]NOP-1A PET Scan conditions</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males or females between 18 and 40 years old

        Exclusion Criteria:

          -  Current DSM-5 psychiatric disorders

          -  Binge drinking as defined in NIAAA criteria in the past month

          -  Recreational abuse of opiates, sedative-hypnotics, cocaine, amphetamines, MDMA, and
             PCP, as well as cannabis use

          -  Currently on any prescription medical or psychotropic medication;

          -  Current or past severe medical, endocrine, cardiovascular, immunological or
             neurological illnesses

          -  Currently pregnant or breast-feeding;

          -  History of radioactivity exposure via prior nuclear medicine studies or occupational
             exposure in past twelve months

          -  Metallic objects in the body that are contraindicated for MRI;

          -  First-degree relative with psychosis or mood disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>September 29, 2017</study_first_submitted>
  <study_first_submitted_qc>October 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 5, 2017</study_first_posted>
  <last_update_submitted>July 1, 2020</last_update_submitted>
  <last_update_submitted_qc>July 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Rajesh Narendran</investigator_full_name>
    <investigator_title>Visiting Professor in Radiology</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocortisone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

